ZyGEM Corporation Appoints Vice President of Business Development

SOLANA BEACH, Calif., Jan. 24 /PRNewswire/ -- ZyGEM Corp. Ltd., a leading provider of unique and innovative enzymatic solutions for DNA extraction, detection and other life sciences applications, today announced the appointment of Susan Barker as vice president of business development. Ms. Barker has more than 20 years of international business development, marketing and sales experience with biotechnology and medical supply companies, including GE Healthcare Lifesciences and Becton Dickinson. She will focus on identifying global opportunities for expanding ZyGEM’s partnerships and reach in multiple markets, including research, clinical and forensic applications.

“Susan’s broad, hands-on experience in international life sciences marketing and business development will be invaluable as we accelerate our product development and global partnering efforts,” said Paul Kinnon, president and CEO of ZyGEM. “We are delighted to have recruited an individual with her strong commercial background, exceptional reputation and successful track record in introducing new technologies and developing business partnerships, which make her a great addition to ZyGEM’s leadership team.”

ZyGEM develops and markets innovative solutions for life sciences applications that leverage the properties of unique enzymes in the company’s extensive proprietary culture collection. Its products include innovative DNA extraction and detection solutions for forensics, livestock and agriculture, basic research and clinical applications. ZyGEM’s technology is based on more than two decades of research and development on the company’s exclusive collection of microorganisms and fungi isolated from extreme environments.

“This is an exciting time to join ZyGEM, as the company prepares to expand its innovative enzyme-based technologies into new markets and additional geographies,” said Ms. Barker. “I already see a range of opportunities in both research and applied markets where ZyGEM’s unique technologies will add significant value. I look forward to working with this talented and energetic team to establish creative collaborations that will address market needs and help drive the rapid growth of ZyGEM.”

Prior to joining ZyGEM, Ms. Barker was director, business development and director, strategic opportunities for GE Healthcare Lifesciences, where she developed new business opportunities. Previously, she was director of regional marketing at GE Healthcare for genomics, proteomics and drug discovery products, where she was involved in the successful launch of several new instrument and reagent platform technologies. Before joining GE, Ms. Barker was global marketing leader for high throughput screening at Becton Dickinson, where she helped establish a leading market position by launching more than 150 new screening products in a 12-month period. Earlier in her career, Ms. Barker held technical support and sales positions of increasing responsibility at Millipore Corporation. She holds a BA in Biology and MA in Microbiology from Boston University, a post-graduate certificate in Marketing from Long Island University and five patents.

ZyGEM recently announced the opening of its new U.S. headquarters in Solana Beach, California.

About ZyGEM

ZyGEM Corporation Limited is a rapidly growing biotechnology company with a range of innovative enzyme-based products and technologies based on the company’s exclusive collection of microorganisms from extreme environments. ZyGEM’s technology has significant competitive advantages over existing methods and has potential applications in a number of sizeable global markets. ZyGEM currently produces DNA extraction and detection products, molecular biology enzymes and individual enzymes and diagnostics, serving life sciences customers in basic research, forensics, clinical diagnostics and agriculture. ZyGEM has facilities in New Zealand and the U.S. For more information, visit http://www.ZyGEM.com.

CONTACT: Corporate: Paul Kinnon, President and CEO, ZyGEM,
+1-858-720-8333; Media: Barbara Lindheim, GendeLLindheim BioCom Partners,
+1-212-918-4650

Web site: http://www.ZyGEM.com/

MORE ON THIS TOPIC